Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy

Journal of International Medical Research

Volumn 44, Issue 2, 2016, Pages 278-286

  Wang, Yuan ^a   Li, Yan Mei ^a   Zhang, Shu ^a   Zhao, Jiu Yang ^a   Liu, Chun Yan ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

albuminuria; biomarker; diabetic nephropathy; Zinc alpha 2 glycoprotein

Indexed keywords

ADIPOCYTOKINE; ALBUMIN; BIOLOGICAL MARKER; CREATININE; UNCLASSIFIED DRUG; ZINC ALPHA 2 GLYCOPROTEIN; SEMINAL PLASMA PROTEIN; SERUM ALBUMIN; ZN-ALPHA-2-GLYCOPROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; AGED; ALBUMINURIA; BLOOD; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; METABOLISM; PATHOPHYSIOLOGY; URINE;

ADULT; AGED; ALBUMINURIA; BIOMARKERS; CASE-CONTROL STUDIES; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; SEMINAL PLASMA PROTEINS; SERUM ALBUMIN;

EID: 84961621837     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060515601699     Document Type: Article

References (33)

1. International Diabetes Federation. IDF Diabetes Atlas Sixth edition, https://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf (2013, accessed 6 January 2016)
2. A.T.Reutens. Epidemiology of diabetic kidney disease. Med Clin North Am2013; 97: 1–18.
3. C.Mora-FernándezV.Domínguez-PimentelM.M.de Fuentes. Diabetic kidney disease: from physiology to therapeutics. J Physiol2014; 592: 3997–4012.
4. P.FiorettoM.Mauer. Histopathology of diabetic nephropathy. Semin Nephrol2007; 27: 195–207.
5. M.C.ThomasW.C.BurnsM.E.Cooper. Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis2005; 12: 177–186.
6. G.TramontiY.S.Kanwar. Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy. Endocrine2013; 43: 494–503.
7. A.MathesonM.D.WillcoxJ.Flanagan. Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev2010; 26: 150–171.
8. W.J.FuS.L.XiongY.G.Fang. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine2012; 41: 82–88.
9. M.I.HassanA.WaheedS.Yadav. Zinc alpha 2-glycoprotein: a multidisciplinary protein. Mol Cancer Res2008; 6: 892–906.
10. M.W.KennedyA.P.HeikemaA.Cooper. Hydrophobic ligand binding by Zn-alpha 2-glycoprotein, a soluble fat-depleting factor related to major histocompatibility complex proteins. J Biol Chem2001; 276: 35008–35013.
11. J.R.PoortmansK.Schmid. The level of Zn-alpha 2-glycoprotein in normal human body fluids and kidney extract. J Lab Clin Med1968; 71: 807–811.
12. C.BingY.BaoJ.Jenkins. Zinc-alpha2 glycoprotein, a lipid mobilizing factor is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci USA2004; 101: 2500–2505.
13. L.E.OlofssonB.OlssonT.Lystig. Preliminary report: Zn-alpha2-glycoprotein genotype and serum levels are associated with serum lipids. Metabolism2010; 59: 1316–1318.
14. A.PhilippS.KralischA.Bachmann. Serum levels of the adipokine zinc-α2-glycoprotein are increased in chronic hemodialysis. Metabolism2011; 60: 669–672.
15. F.QuX.YingW.Guo. The role of Zn-alpha2 glycoprotein in sperm motility is mediated by changes in cyclic AMP. Reproduction2007; 134: 569–576.
16. L.P.Hale. Zinc alpha-2-glycoprotein regulates melanin production by normal and malignant melanocytes. J Invest Dermatol2002; 119: 464–470.
17. L.P.HaleD.T.PriceL.M.Sanchez. Zinc alpha-2-glycoprotein is expressed by malignant prostatic epithelium and may serve as a potential serum marker for prostate cancer. Clin Cancer Res2001; 7: 846–853.
18. He N, Brysk H, Tyring SK, et al. Zinc-alpha(2)-glycoprotein hinders cell proliferation and reduces cdc2 expression. J Cell Biochem Suppl 2001; Suppl 36: 162–169
19. D.C.YeungK.S.LamY.Wang. Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects. J Clin Endocrinol Metab2009; 94: 2531–2536.
20. D.StejskalM.KarpísekH.Reutová. Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA. Clin Biochem2008; 41: 313–316.
21. S.T.RussellM.J.Tisdale. Antidiabetic properties of zinc-alpha2-glycoprotein in ob/ob mice. Endocrinology2010; 151: 948–957.
22. S.JainA.RajputY.Kumar. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder. J Assoc Physicians India2005; 53: 513–520.
23. S.A.VargheseT.B.PowellM.N.Budisavljevic. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol2007; 18: 913–922.
24. T.TadaI.OhkuboM.Niwa. Immunohistochemical localization of Zn-alpha2-glycoprotein in normal human tissues. J Histochem Cytochem1991; 39: 1221–1226.
25. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 diabetes. Brussels: International Diabetes Federation, 2005, https://www.idf.org/webdata/docs/IDF%20GGT2D.pdf (accessed 17 December 2015)
26. A.S.LeveyJ.P.BoschJ.B.Lewis. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med1999; 130: 461–470.
27. W.F.KeaneG.Eknoyan. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation. Am J Kidney Dis1999; 33: 1004–1010.
28. J.M.Halimi. The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients. Diabetes Metab2012; 38: 291–297.
29. W.J.FuB.L.LiS.B.Wang. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration. Diabetes Res Clin Pract2012; 95: 105–109.
30. V.VallonS.C.Thomson. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol2012; 74: 351–375.
31. S.E.NielsenS.AndersenD.Zdunek. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int2011; 79: 1113–1118.
32. S.C.LimD.Q.LiyingW.C.Toy. Adipocytokine zinc α2 glycoprotein (ZAG) as a novel urinary biomarker for normo-albuminuric diabetic nephropathy. Diabet Med2012; 29: 945–949.
33. R.SchmittA.MarlierL.G.Cantley. Zag expression during aging suppresses proliferation after kidney injury. J Am Soc Nephrol2008; 19: 2375–2383.